COVID-19 Delta Variant Q & with Drs. Cindy Gay and David Wohl

Watch this Q&A with UNC School of Medicine infectious diseases experts Cindy Gay, MD, who leads vaccine clinical trials at UNC for the Moderna and Novavax vaccines, and co-investigator David Wohl, who led the UNC-Chapel Hill vaccine clinic and heads the monoclonal antibody treatment clinic for UNC Health. They answer questions about the COVID-19 Delta variant and vaccine efficacy and safety. F

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.